Skip to main content

Macrophage elimination in bone marrow by dexamethasone palmitate is associated with successful engraftment in patients with hemophagocytic syndrome

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Nishiwaki S, Nakayama T, Murata M, Nishida T, Sugimoto K, Saito S, et al. Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy. Int J Hematol. 2012;95(4):428–33.

    Article  CAS  PubMed  Google Scholar 

  2. 2.

    Sakaguchi H, Matsumoto K, Yoshida N, Narita K, Hamada M, Kataoka S, et al. Dexamethasone palmitate for patients with engraftment syndrome is associated with favorable outcome for children with hematological malignancy. Bone Marrow Transpl. 2016;51(11):1540–2.

    Article  CAS  Google Scholar 

  3. 3.

    Takagi S, Masuoka K, Uchida N, Ishiwata K, Araoka H, Tsuji M, et al. High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults. Br J Haematol. 2009;147(4):543–53.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the staff of the hematopoietic stem cell transplantation team at Okayama University Hospital.

Author information

Affiliations

Authors

Contributions

HS managed the clinical practice and wrote the paper. KM supervised the clinical practice and edited the paper. MM, SI, TI, TK, TA, and SY advised and edited the paper. HN, KF, NF, and YM supervised clinical practice.

Corresponding author

Correspondence to Ken-ichi Matsuoka.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest. A summary of relevant information will be published with the manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 72 kb)

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sugiura, H., Matsuoka, Ki., Matsuda, M. et al. Macrophage elimination in bone marrow by dexamethasone palmitate is associated with successful engraftment in patients with hemophagocytic syndrome. Int J Hematol 110, 260–262 (2019). https://doi.org/10.1007/s12185-019-02659-1

Download citation

Keywords

  • Transplantation
  • Hemophagocytic syndrome
  • Dexamethasone palmitate